A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...

CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.

CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy. The scientists from the University of Leipzig Medical Center, the Fraunhofer ...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS ...

CAR-T cell therapy achieves 18-year survival milestone in cancer patient Innovative cancer treatment shows promise as ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

The US researchers at the Baylor College of Medicine, Texas Children’s Hospital have said the follow-up observations mark the ...

A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years. “This is ...